Pathology of inhalational anthrax infection in the african green monkey

Veterinary Pathology

Volumn 44, Issue 5, 2007, Pages 716-721

  Twenhafel, Nancy A ^a   Leffel, E ^a   Pitt, M L M ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

African green monkeys; Anthrax; Bacillus anthracis; Biologic warfare agent; Inhalation anthrax disease; Rhesus macaques

Indexed keywords

ANIMAL; ANTHRAX; ARTICLE; BRAIN; CERCOPITHECUS; DISEASE MODEL; EXPOSURE; FEMALE; LUNG; LYMPH NODE; MALE; MEDIASTINUM; PATHOLOGY;

ANIMALS; ANTHRAX; BRAIN; CERCOPITHECUS AETHIOPS; DISEASE MODELS, ANIMAL; FEMALE; INHALATION EXPOSURE; LUNG; LYMPH NODES; MALE; MEDIASTINUM;

BACILLUS ANTHRACIS; BACTERIA (MICROORGANISMS); CERCOPITHECIDAE; CERCOPITHECUS AETHIOPS; MACACA; MACACA MULATTA; PRIMATES;

EID: 34548839106     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1354/vp.44-5-716     Document Type: Article

References (11)

1. Berdjis CC, Gleiser CA, Hartman HA, Kuehne RW, Gochenour WS: Pathogenesis of respiratory anthrax in Macaca mulatta. Br J Exp Pathol 43:515-524, 1962
2. Binhazim AA, Shin SS, Chapman WL Jr, Olobo J: Comparative susceptibility of African green monkeys (Cercopithecus aethiops) to experimental infection with Leishmania leishmania donovani and Leishmania leishmania infantum. Lab Anim Sci 43(1):37-47, 1993
3. Durbin AP, Cho CJ, Elkins WR, Wyatt LS, Moss B, Murphy BR: Comparison of the immunogenicity and efficacy of a replication-defective vaccinia virus expressing antigens of human parainfluenza virus type 3 (HPIV3) with those of a live attenuated HPIV3 vaccine candidate in rhesus monkeys passively immunized with PIV3 antibodies. J Infect Dis 179:1345-1351, 1999
4. Fritz DL, Jaax NK, Lawrence WB, Davis KJ, Pitt MLM, Ezzell JW, Friedlander AM: Pathology of experimental inhalation anthrax in the rhesus monkey. Lab Invest 73:691-702, 1995
5. Gleiser CA, Berdjis CC, Hartman JA, Gochenour WS: Pathology of anthrax infection in animal hosts. Fed Proc 26:1518-1521, 1967
6. Gleiser CA, Berdjis CC, Hartman JA, Gochenour WS: Pathology of experimental respiratory anthrax in Macaca mulatta. Br J Exp Pathol 44:416-426, 1963
7. Guarner J, Jernigan JA, Shieh W, Tatti K, Flannagan LM, Stephens DS, Popovic T, Ashford DA, Perkins BA, Zaki SR, Inhalational Anthrax Pathology Working Group, Pathology and pathogenesis of bioterrorism-related inhalational anthrax. Am J Pathol 163:701-709, 2003
8. Hartings JM, Roy CJ: The automated bioaerosol exposure system: Preclinical platform development and a respiratory dosimetry application with nonhuman primates. J Pharmacol Toxicol Methods 49:39-55, 2004
9. Ivins BE, Welkos SL, Knudson GB, Little SF: Immunization against anthrax with aromatic compound-dependent (Aro-) mutants of Bacillus anthracis and with recombinant strains of Bacillus subtilis that produce protective antigen. Infect Immun 58:303-308, 1990
10. Olobo JO, Gicheru MM, Anjili CO: The African green monkey model for cutaneous and visceral leishmaniasis. Trends Parasitol 17(12):588-592, 2001
11. Reed DS, Lind CM, Lackemeyer MG, Sullivan LJ, Pratt WD, Parker MD: Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus. Vaccine 23:3139-3147, 2005 Vet Pathol 44:722-726 (2007)